The Efficacy of Sequential Therapy as Second Line Therapy for Refractory Helicobacter Pylori Infection - A Pilot Study
NCT00885417
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
142
Enrollment
OTHER
Sponsor class
Conditions
H. Pylori Infection
Interventions
DRUG:
Cravit-based sequential therapy
Sponsor
National Taiwan University Hospital